SCHEMBL24968868

SCHEMBL24968868

COc1ncc(CCCC(=O)O)cc1C(F)(F)F

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 7/20 0.50
PPARG P37231 1/20 0.42
PPARA Q07869 1/20 0.42
FFAR4 Q5NUL3 3/20 0.41
NR1H4 Q96RI1 1/20 0.38
RXRA P19793 2/20 0.38
NR1H2 P55055 2/20 0.38
HDAC3 O15379 1/20 0.37
MAPK1 P28482 1/20 0.37
ADRA1A P35348 1/20 0.37
HDAC4 P56524 1/20 0.37
SLC6A3 Q01959 1/20 0.37
HDAC1 Q13547 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HDAC7 Q8WUI4 1/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC10 Q969S8 1/20 0.37
HDAC11 Q96DB2 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30851277 1.00 S1PR1 (0.50) S1PR1PPARGPPARAFFAR4NR1H4
SCHEMBL30851253 0.83 SMN1; SMN2 (0.47) S1PR1RXRASMN1; SMN2SLC13A5SLC13A2
SCHEMBL24967935 0.83 SMN1; SMN2 (0.47) S1PR1RXRASMN1; SMN2SLC13A5SLC13A2
SCHEMBL24968228 0.80 AURKA (0.37) S1PR1
SCHEMBL30851115 0.80 AURKA (0.37) S1PR1
SCHEMBL27233770 0.80 TACR1 (0.36) S1PR1HDAC3HDAC4HDAC6SLC13A5
SCHEMBL29165939 0.78 PIK3R1 (0.36) S1PR1
SCHEMBL24967942 0.78 LMNA (0.39) S1PR1SMN1; SMN2
SCHEMBL30851110 0.78 LMNA (0.39) S1PR1SMN1; SMN2
SCHEMBL24968405 0.77 HTR2A (0.45) S1PR1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117642393-A Novel PARP7 inhibitor and application thereof 上海齐鲁制药研究中心有限公司 2024-03-01 CN disclosed
WO-2023006013-A1 NOVEL PARP7 INHIBITOR AND USE THEREOF 上海齐鲁制药研究中心有限公司 2023-02-02 WO disclosed